Status:

COMPLETED

Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor

Lead Sponsor:

University Medical Centre Ljubljana

Collaborating Sponsors:

Slovenian Research Agency

Conditions:

Preterm Birth

Eligibility:

FEMALE

18-48 years

Phase:

NA

Brief Summary

The investigators study objective is to investigate the effectiveness of vaginal micronized progesterone in prolonging pregnancy after an episode of preterm labor which responded to tocolytic treatmen...

Eligibility Criteria

Inclusion

  • Patients with singleton pregnancies at gestational ages 25+0 to 33+6 weeks after an episode of preterm labor, with cervical length ≤25mm:
  • Patients presenting with signs and symptoms of preterm labor will be admitted and given the standard treatment for preterm labor, i.e. tocolysis for 48 hours, and antenatal steroids.
  • Those who will remain undelivered for 48 hours and will be found to have a cervical length of 25mm or less will be offered entrance into the study.
  • Preterm labor will be defined as at least 4 contractions in 30 minutes with cervical change assessed by digital cervical examination.

Exclusion

  • Patients with preterm premature rupture of membranes (PPROM) will be excluded from the study, due to the possibility of ascending infection, as will those with suspected chorioamnionitis.
  • We will not include multiple pregnancies.
  • Patients with medical conditions that contraindicate tocolysis, such as non-reassuring fetal heart tracings, will also be excluded.

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2015

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01523483

Start Date

March 1 2012

End Date

March 1 2015

Last Update

April 22 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Univerity Medical Centre Ljubljana

Ljubljana, Slovenia, 1000